Skip to main content
. 2013 Mar 5;13:31. doi: 10.1186/1471-2288-13-31

Table 1.

Comparison of OCS participants’ characteristics between the participating and non-participating sites in the representativeness study

 
All sites
4 sites in representativeness study
Other sites
 
Characteristics   (n=3106) (n=1861) (n=1245) p value
Age
 
46 (40–52)
46 (40–52)
46 (40–52)
0.77
Male
 
2628 (85%)
1632 (88%)
996 (80%)
<.0001
Risk factor
 
 
 
 
 
 
MSM
2133 (71%)
1429 (77%)
704 (60%)
<.0001
 
IDU
364 (12%)
180 (10%)
184 (16%)
<.0001
 
heterosexual
629 (21%)
325 (18%)
304 (26%)
<.0001
 
Blood product/MTCT
197 (6%)
102 (5%)
95 (8%)
0.009
Race
 
 
 
 
0.02
 
Caucasian
2170 (72%)
1329 (72%)
841 (72%)
 
 
Black/African
418 (14%)
259 (14%)
159 (14%)
 
 
Aboriginal
161 (5%)
83 (4%)
78 (7%)
 
 
Other
264 (9%)
176 (10%)
88 (8%)
 
Born in Canada
 
2090 (69%)
1264 (69%)
826 (70%)
0.35
Years since HIV+ test
 
11 (6–17)
12 (5–18)
11 (6–17)
0.41
Cigarette history
 
 
 
 
0.006
 
Never
1017 (35%)
623 (35%)
394 (35%)
 
 
Former
736 (25%)
479 (27%)
257 (23%)
 
 
Current
1161 (40%)
671 (38%)
490 (43%)
 
Alcohol use
 
1102 (38%)
718 (40%)
384 (34%)
0.0003
Substance use
 
614 (21%)
414 (23%)
200 (18%)
0.0002
Education
 
 
 
 
<.0001
 
High school or lower
929 (32%)
504 (28%)
425 (37%)
 
 
Some/completed college
890 (30%)
545 (31%)
345 (30%)
 
 
Some/completed university
1102 (38%)
732 (41%)
370 (32%)
 
Employed
 
1401 (48%)
920 (52%)
481 (42%)
<.0001
Household income
 
 
 
 
<.0001
 
< 30 K
1062 (40%)
566 (35%)
496 (47%)
 
 
30-60 K
612 (23%)
378 (24%)
234 (22%)
 
 
60-80 K
298 (11%)
189 (12%)
109 (10%)
 
 
> 80 K
693 (26%)
470 (29%)
223 (21%)
 
General health
 
 
 
 
<.01
 
Good
2353 (81%)
1466 (82%)
887 (78%)
 
 
Fair
464 (16%)
248 (14%)
216 (19%)
 
 
Poor
103 (4%)
65 (4%)
38 (3%)
 
On cART
 
2497 (80%)
1487 (80%)
1010 (81%)
0.40
CD4 count (cells/mm3)
 
471 (330–650)
480 (340–650)
460 (310–649)
0.02
VL < 50 copies/mL   2254 (73%) 1379 (74%) 875 (70%) 0.02

OCS Ontario HIV Treatment Network Cohort Study, MSM men who have sex with men, IDU injection drug use, MTCT mother to child transmission, cART combination antiretroviral therapy, VL viral load.

Numbers are reported as median (interquartile range) or frequency (percentage).